E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors
Life Science Alliance · 2024-09 · 7 (9) · e202402575
DOI: 10.26508/lsa.202402575 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 05.07.2024. Verfasst von Jeroen M Bugter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands. Hauptthemen laut MEDLINE: Frizzled Receptors, Endocytosis, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, KWF Kankerbestrijding, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
The transmembrane E3 ligases RNF43 and ZNRF3 perform key tumour suppressor roles by inducing endocytosis of members of the Frizzled (FZD) family, the primary receptors for WNT. Loss-of-function mutations in RNF43 and ZNRF3 mediate FZD stabilisation and a WNT-hypersensitive growth state in various cancer types. Strikingly, RNF43 and ZNRF3 mutations are differentially distributed across cancer types, raising questions about their functional redundancy. Here, we compare the efficacy of RNF43 and ZNRF3 of targeting different FZDs for endocytosis. We find that RNF43 preferentially down-regulates FZD1/FZD5/FZD7, whereas ZNRF3 displays a preference towards FZD6. We show that the RNF43 transmembrane domain (TMD) is a key molecular determinant for inducing FZD5 endocytosis. Furthermore, a TMD swap between RNF43 and ZNRF3 re-directs their preference for FZD5 down-regulation. We conclude that RNF43 and ZNRF3 preferentially down-regulate specific FZDs, in part by a TMD-dependent mechanism. In accordance, tissue-specific expression patterns of FZD homologues correlate with the incidence of RNF43 or ZNRF3 cancer mutations in those tissues. Consequently, our data point to druggable vulnerabilities of specific FZD receptors in RNF43 - or ZNRF3 -mutant human cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands.
- Oncode Institute and Centre for Molecular Medicine, UMC Utrecht, Utrecht, Netherlands m.m.maurice@umcutrecht.nl.
ORCID-Profile: Cara Jamieson, Madelon M Maurice
Förderung
- ZonMw
- KWF Kankerbestrijding
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- KWF Kankerbestrijding/TKI-Life Sciences and Health
Zitieren
APA
Bugter, J. M., van Kerkhof, P., Jordens, I., Janssen, E., Tran Ngoc Minh, T., Iglesias van Montfort, D., Jamieson, C., & Maurice, M. M. (2024). E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. Life Science Alliance, 7(9), e202402575. https://doi.org/10.26508/lsa.202402575
Vancouver
Bugter JM, van Kerkhof P, Jordens I, Janssen E, Tran Ngoc Minh T, Iglesias van Montfort D, et al. E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. Life Science Alliance. 2024;7(9):e202402575. doi:10.26508/lsa.202402575
BibTeX
@article{Bugter2024,
author = {Bugter, Jeroen M and van Kerkhof, Peter and Jordens, Ingrid and Janssen, Eline and Tran Ngoc Minh, Thi and Iglesias van Montfort, Daniel and Jamieson, Cara and Maurice, Madelon M},
title = {E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors},
journal = {Life Science Alliance},
year = {2024},
volume = {7},
number = {9},
pages = {e202402575},
doi = {10.26508/lsa.202402575}
}
EUVIMED